Proactive research analyst John Savin speaks to Thomas Warner about his latest research note on Creo Medical Group PLC (AIM:CREO).
He gives his take on how the group is currently performing, suggesting that it is currently worth "about £100mln", and looks ahead to what investors can expect from it over the coming years.